| |
|
|
|
Capricor Therap  
|
|
5.71 0.32 (0.06%) |
01-22 16:00 |
|
Open: |
5.28 |
Pre close: |
5.39 |
Target:
|
6.96
|
|
High: |
5.75 |
Low: |
5.2 |
Resistance:
|
5.96
6.96
|
|
Volume: |
847,421 |
Market Cap: |
117M |
Support:
|
4.33
3.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.36
 |
MACD |
MACD(12,26):
|
0.36 |
|
MA(20): |
4.38 |
Signal(12,26,9): |
0.18 |
|
MA(100): |
4.56 |
Stochastic Oscillator |
%K(14,3):
|
81.06 |
|
MA(250): |
4.20 |
%D(3): |
76.85 |
|
Average Volume(K) |
3-Month: |
77858
|
52-Week |
High:
|
12.32 |
|
10-Days: |
203393 |
Low: |
0.88 |
|
RSI |
RSI(14):
|
70.46 |
Change(%): |
254.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.948 |
Return on Equity (ttm) |
-64.4 |
Shares Out. (M) |
20.45 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
-31.2 |
Shares Float (M) |
19.93 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.53 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-88.1 |
% Held by Institutions |
6.20 |
|
Forward EPS |
-2.060 |
Gross Profit (p.s.) |
-0.202 |
Shares Short (K) |
765 |
|
Book Value (p.s.) |
1.500 |
EBITDA (p.s.) |
-0.531 |
P/E |
-6.05 |
|
Sales Per Share |
0.023 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.83 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.00 |
P/S |
247.37 |
|
Operating Margin |
-2316.61 |
Levered Free Cash Flow
(M) |
-3.98 |
P/CF |
-14.67 |
|
|
|
|
|
|
